which is necessary to improve the design of oxidant-or antioxidant-based therapeutic strategies for the treatment of cancer. In primary research articles by Chatterjee et al. [8] and Heer et al. [9] , these investigators use SOD mimetics to enhance anti-cancer treatment. Chatterjee et al. [8] demonstrate that SOD mimetics, in combination with radiation, inhibit prostate cancer growth while simultaneously protecting the normal prostate tissue from radiation damage. Heer et al. [9] enhance the anti-tumor effect of pharmacological ascorbate with the addition of SOD mimetics by enhancing hydrogen peroxide levels in the tumor.
Radiation-induced fibrosis is caused in large part from free radical production, which results in damage to normal tissues. SOD overexpression has been shown to mitigate radiation-induced damage. Studies conducted by Cline et al. [10] and Shrishrimal et al. [11] demonstrate that SOD mimetics protect from radiation-induced fibrosis. In a lung fibrosis model, Cline et al. [10] demonstrate that the addition of a SOD mimic after whole thorax radiation exposure protects from lung fibrosis. In a pelvic irradiation model, Shrishrimal et al. [11] show that a SOD mimic prevented acute and chronic irradiation damage in pelvic tissues and demonstrated that SOD treatment prevents myofibroblast differentiation that is induced by radiation exposure.
MnSOD plays a critical role in maintaining redox balance in the mitochondria and thereby also helps to regulate cellular metabolism. In metabolic diseases, such as diabetes, there are high amounts of systemic oxidative stress along with dysfunctional mitochondria. Coudriet et al. [12] show that a SOD mimetic protects from liver damage, improves insulin sensitivity, and reduces inflammation associated with obesity-induced type 2 diabetes. In a chemical induced model of mitochondrial oxidative stress and altered metabolism, Alam et al. [13] demonstrate that exogenous MnSOD can overcome mitochondrial changes in SIRT3 −/− cells.
ECSOD is highly expressed in the lung, cardiovascular system, and cartilage. Alteration in ECSOD expression is associated with disease in these tissues, and polymorphisms of ECSOD have been identified to contribute to lung and cardiovascular disease. In the primary article by Sherlock et al. [14] , the authors show that a polymorphism of ECSOD, R213G, results in more ECSOD in the serum and less ECSOD bound to the vasculature. The R213G ECSOD mice have abnormal pulmonary vascular development but are better protected from lung injury. ECSOD is highly expressed in cartilage and is thought to protect this tissue from protein oxidation and breakdown. Using impact and overload injury scenarios to bovine osteochondral explants, Coleman et al. [15] demonstrate that the superoxide is produced after high impact to cartilage tissues and the addition of a SOD mimetic protected from cartilage damage.
This special issue demonstrates the diverse functions that SOD enzymes play in normal and diseased states and highlights exciting new SOD mimetics that may provide some therapeutic strategies to prevent or lessen the severity of diseases.
